Zoan Biomed was awarded it’s ISO 13485:2016 certification – the international standard for quality management systems in the medical device industry. This is a fundamental step ahead of market approval and registration of our Zoan G03 product in the US and Europe.
This is the outcome of a multi year effort that has taken our innovative, sustainable and natural solution and translated that into an internationally recognised platform that is ready for manufacturing and human use.
James Martin, Production Director and Flora Joyce, Scientific Officer & QA Lead led the initiation, development, and execution of the Quality Management System supported by the day-to-day expertise of Michael O’Donnell and Rose Mongan.
It gives the company a substantial foundation now to meet the requirements of customers, ensure compliance with regulation and drive excellence in the day-to-day operating practices. Most importantly it is a key step in delivering on our key principle of patient safety
Zoan Biomed has completed its most recent 12 month GLP pre-clinical trial which delivered further exciting results on our materials ability to heal bone and provide outstanding structural stability, while being biocompatible and bioresorbable.